Chapman Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$819K |
| 2 |
Eli Lilly
LLY
|
+$88.8K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.09K |
| 4 |
O'Reilly Automotive
ORLY
|
+$2.07K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$873K |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$817K |
| 3 |
Costco
COST
|
+$812K |
| 4 |
Amazon
AMZN
|
+$708K |
| 5 |
Apple
AAPL
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 24.32% |
| 3 | Consumer Discretionary | 16.16% |
| 4 | Healthcare | 10.33% |
| 5 | Consumer Staples | 9.88% |
Similar funds
Chapman Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Chapman Investment Management held 33 positions worth $132M, down 3.1% from $136M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Chapman Investment Management withdrew a net $7.13M in Q2 2024, closing 1 position and reducing 25 holdings. Its most notable exit was Merck, an estimated $207K position sold in full.
By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Chapman Investment Management opened a new position in Intuitive Surgical worth $915K.
- Chapman Investment Management's largest Q2 2024 buy was Intuitive Surgical: 2,057 shares worth $915K.
- Chapman Investment Management added most to Eli Lilly in Q2 2024, an estimated $88.8K increase.
- Chapman Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $873K.
- Chapman Investment Management fully exited Merck in Q2 2024, selling an estimated $207K.
- Chapman Investment Management's ten largest holdings make up 66% of its $132M portfolio in Q2 2024.
- Chapman Investment Management opened 1 new position and closed 1 in Q2 2024.
- Chapman Investment Management's portfolio value fell 3.1% quarter-over-quarter to $132M.
Based on Chapman Investment Management's 13F filing for Q2 2024, filed 7 Aug 2024.